HeartSciences Inc. (HSCS) Stock

Healthcare · Medical Devices · Member of Other US Stocks

HeartSciences Inc. (HSCS) closed at USD 3.02 on 2026-10-14, a change of -4.4 % over the past year, with a market capitalization of USD 15.4M.

HeartSciences Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

HeartSciences Inc. key figures

Previous close

USD 3.02 (2026-10-14)

1-year change

-4.4 %

Market cap

USD 15.4M

Enterprise value

USD 19.24M

P/E ratio (trailing)

-0.96

P/E ratio (forward)

-1.82

EPS (trailing)

-3.30

EPS (forward)

-1.75

PEG ratio

n/a

Price to book

-6.10

Revenue growth

10.5 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

0.19

Employees

14

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About HeartSciences Inc.

HeartSciences Inc., a medical technology company, focuses on advancing electrocardiography (ECG) through the integration of artificial intelligence. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional ECG information in the same test; and MyoVista Insights, a cloud-native vendor- and device-agnostic ECG management platform. The company was formerly known as Heart Test Laboratories, Inc. and changed its name to HeartSciences Inc. in October 2024. HeartSciences Inc. was incorporated in 2007 and is headquartered in Southlake, Texas.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for HeartSciences Inc. and compare it with other stocks.